Loading...
•
Dec 31, 2025
•/
Organigram Q1 2026 Earnings Report
Estimated Revenue:CA$72.8M
-22.1% YoY
Estimated EPS:-CA$0.0136
+68.3% YoY
Key Takeaways
Organigram delivered strong Q1 Fiscal 2026 performance with robust net revenue growth, a return to net income, and materially improved adjusted EBITDA driven by Canadian market leadership and growing international sales.
Net revenue grew strongly year over year driven by Motif acquisition and international sales
Adjusted EBITDA increased substantially, reflecting improved operating efficiency
Adjusted gross margin expanded due to higher yields and operational synergies
International revenue continued to grow and contributed meaningfully to results
Revenue by Geographic Location
Forward Guidance
Management expects continued improvement in profitability and growth in international sales through Fiscal 2026.
Positive Outlook
- Expected continued international sales growth
- Ongoing operational efficiency improvements
- Higher yields supporting margin expansion
- Benefits from Motif integration synergies
- Strong market position in Canada
Challenges Ahead
- Seasonal and market dynamics may impact near-term results
- Working capital investments may pressure cash flow
- Regulatory uncertainty in international markets
- EU-GMP certification timing remains uncertain
- Macroeconomic conditions could affect demand
Loading...
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...